Insider Trading: Opexa Therapeutics Inc (OPXA.W)
OPXA.W on CBOE When Trading NASDAQ Global Select Market
1.69USD
13 Jun 2013
1.69USD
13 Jun 2013
Price Change (% chg)
$-0.15 (-8.15%)
$-0.15 (-8.15%)
Prev Close
$1.84
$1.84
Open
$1.73
$1.73
Day's High
$1.73
$1.73
Day's Low
$1.69
$1.69
Volume
329
329
Avg. Vol
298
298
52-wk High
$4.91
$4.91
52-wk Low
$1.16
$1.16
JORDEN DAVID EMERSON
| Trading Date | Type | Shares Traded | Price | Shares Held |
|---|---|---|---|---|
| 30 Dec 2012 | Buy | 4,595 | $1.33 | 227,094 |
Institutional Holders
| % Shares Owned: | 5.87% |
| # of Holders: | 12 |
| Total Shares Held: | 473,460 |
| 3 Mo. Net Change: | 61,852 |
| # New Positions: | 8 |
| # Closed Positions: | 2 |
| # Increased Positions: | 8 |
| # Reduced Positions: | 2 |
| # Net Buyers: | 6 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Neil Warma |
49 | 2012 | President, Chief Executive Officer, Director |
Karthik Radhakrishnan |
42 | 2013 | Chief Financial Officer |
Don Healey |
2013 | Chief Scientific Officer | |
Donna Rill |
2013 | Chief Development Officer | |
David Jorden |
50 | 2013 | Director |
Gail Maderis |
55 | 2011 | Independent Director |
Michael Richman |
51 | 2006 | Independent Director |
Scott Seaman |
57 | 2006 | Independent Director |

